Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Autoimmunity

Background:

• Multiple sclerosis (MS) is a central nervous system (CNS) autoimmune disease affecting over 2.5 million people globally.
• Significant sex-based disparities exist in MS susceptibility and disease progression, with females being more commonly diagnosed but males potentially experiencing faster progression.

Purpose of the Study:

• To review the immunological basis for observed sex differences in MS susceptibility and disease outcome.
• To explore how sex differences in immune responses influence disease progression and therapeutic responses in MS.
• To highlight the role of animal models, such as experimental autoimmune encephalomyelitis (EAE), in understanding these sex-based immunological variations.

Main Methods:

• Review of existing literature on sex differences in MS and related autoimmune diseases.
• Analysis of data from animal models (EAE) investigating sex-specific immune responses.
• Discussion of the role of T helper 17 (Th17) responses in sex-based disease onset and severity.

Main Results:

• Females exhibit higher susceptibility to MS, while disease progression may be more rapid in males.
• Evidence from EAE models suggests sex differences in innate and adaptive immune responses contribute to disease outcomes.
• Female mice show earlier disease onset linked to stronger Th17 immune responses.

Conclusions:

• Sex differences in immune responses are critical factors in MS pathogenesis and progression.
• Understanding these immunological variations is essential for developing sex-specific therapeutic strategies for MS.
• Further research into sex differences in response to disease-modifying therapies may optimize patient treatment outcomes.